| P2093 | author name string | Adnan I Qureshi | |
| | M Fareed K Suri | |
| | Nizar Souayah | |
| | Abu Nasar | |
| P2860 | cites work | Guillain-Barré syndrome | Q24276200 |
| | Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern | Q28275022 |
| | Neurologic adverse events associated with smallpox vaccination in the United States, 2002-2004. | Q33991923 |
| | Influenza infection in patients before and after liver transplantation | Q34026783 |
| | Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977 | Q34215590 |
| | Guillain-Barré syndrome following influenza vaccination | Q34370829 |
| | The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines. | Q50852734 |
| | Safety and efficacy of two types of influenza vaccination in heart transplant recipients: a prospective randomised controlled study | Q57000068 |
| | No Association Between Immunization and Guillain-Barré Syndrome in the United Kingdom, 1992 to 2000 | Q57388524 |
| | Reassessment of the Association between Guillain-Barré Syndrome and Receipt of Swine Influenza Vaccine in 1976–1977: Results of a Two-State Study | Q64128491 |
| | Risk of Guillain-Barré syndrome after measles-mumps-rubella vaccination | Q73432406 |
| | Assessment: Neurologic risk of immunization: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology | Q77759492 |
| P433 | issue | 29 | |
| P921 | main subject | Vaccine Adverse Event Reporting System | Q7907943 |
| | Guillain–Barré syndrome | Q205214 |
| | vaccine adverse event | Q445335 |
| P304 | page(s) | 5253-5255 | |
| P577 | publication date | 2007-05-22 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Guillain-Barre syndrome after vaccination in United States a report from the CDC/FDA Vaccine Adverse Event Reporting System | |
| P478 | volume | 25 | |